LILRA3 Is Associated with Benign Prostatic Hyperplasia Risk in a Chinese Population

LILRA3 Is Associated with Benign Prostatic Hyperplasia Risk in a Chinese Population

A recent prostate cancer (PCa) genome-wide association study (GWAS) identified rs103294, a single nucleotide polymorphism (SNP) located on LILRA3, a key component in the regulation of inflammatory inhibition, to be significantly associated with PCa risk in a Chinese population. Because inflammation...

Full description

Bibliographic Details
Main Authors:	Jiao, Yang, Wang, Li, Gu, Xin, Tao, Sha, Tian, Lu, Na, Rong, Chen, Zhuo, Kang, Jian, Zheng, Siqun L., Xu, Jianfeng, Sun, Jielin, Qi, Jun
Format:	Online
Language:	English
Published:	Molecular Diversity Preservation International (MDPI) 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676759/

Similar Items

Association of a Common Variant at 10q26 and Benign Prostatic Hyperplasia Aggressiveness in Han Chinese Descent
by: Gu, Xin, et al.
Published: (2013)

Benign Prostatic Hyperplasia
Published: (2015)

Testosterone and benign prostatic hyperplasia
by: Jarvis, Thomas R, et al.
Published: (2015)

Laparoscopic simple prostatectomy with prostatic urethra preservation for benign prostatic hyperplasia
by: Xing, Nianzeng, et al.
Published: (2012)

Management of benign prostatic hyperplasia with silodosin
by: Yamanishi, Tomonori, et al.
Published: (2009)

Epidemiology of clinical benign prostatic hyperplasia
by: Kok Bin Lim
Published: (2017-07-01)

Pathophysiology of clinical benign prostatic hyperplasia
by: Keong Tatt Foo
Published: (2017-07-01)

Tuberculosis of the prostate presenting as benign prostatic hyperplasia.
by: Fazarina M,, et al.
Published: (2013)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
by: Wiwanitkit, Somsri, et al.
Published: (2012)

Tuberculosis of the prostate presenting as benign prostatic hyperplasia
by: Perpustakaan Tun Seri Lanang
Published: (2013)

Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men
by: Yin, Zhuo, et al.
Published: (2015)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
by: Protopsaltis, Ioannis, et al.
Published: (2013)

Transitional Zone Index and Intravesical Prostatic Protrusion in Benign Prostatic Hyperplasia Patients: Correlations according to Treatment Received and Other Clinical Data
by: Huang, Tao, et al.
Published: (2012)

Transurethral ethanol ablation for symptomatic benign prostatic hyperplasia
by: Gautam, Gagan, et al.
Published: (2007)

Cystic benign prostatic hyperplasia in a dog
by: Tan, W. X., et al.
Published: (2015)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
by: Gupta, Shivaji, et al.
Published: (1997)

Benign prostatic hyperplasia: An overview of existing treatment
by: Dhingra, Neelima, et al.
Published: (2011)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
by: McMahon, M. J., et al.
Published: (1973)

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
by: Yoshida, Masaki, et al.
Published: (2011)

Benign Prostatic Hyperplasia: from Bench to Clinic
by: Yoo, Tag Keun, et al.
Published: (2012)

Unsolved Issues in Managing Benign Prostatic Hyperplasia
by: Oh, Seung-June
Published: (2013)

Fibronectin Pattern in Benign Hyperplasia and Cancer of the Prostate
by: Janković, Miroslava M., et al.
Published: (2008)

Suppression of benign prostate hyperplasia by Kaempferia parviflora rhizome
by: Murata, Kazuya, et al.
Published: (2013)

Cystic benign prostatic hyperplasia in a dog
by: Husna Zayadi
Published: (2015)

Metabolic syndrome and benign prostatic hyperplasia: An update
by: Ho-Yin Ngai, et al.
Published: (2017-07-01)

Development of Medical Lasers for Treatment on Benign Prostatic Hyperplasia
by: Xiao-Lei Ren, et al.
Published: (2018-01-01)

Oxidative Stress in Patients with Benign Prostate Hyperplasia
by: Madhukar Aryal, et al.
Published: (2007-07-01)

Recent Advances in the Management of Benign Prostatic Hyperplasia
by: Chandra Shekhar Agrawal
Published: (2003-01-01)

Diagnosis and treatment of benign prostate hyperplasia in Asia
by: Foo, Keong Tatt
Published: (2015)

Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia
by: El-Tabey, Magdy, et al.
Published: (2015)

Chromosomal aberrations in benign prostatic hyperplasia patients
by: Altok, Muammer, et al.
Published: (2016)

Korean clinical practice guideline for benign prostatic hyperplasia
by: Yeo, Jeong Kyun, et al.
Published: (2016)

Recent advances in treatment for Benign Prostatic Hyperplasia
by: van Rij, Simon, et al.
Published: (2015)

Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?
by: Rył, Aleksandra, et al.
Published: (2015)

Giant Benign Prostatic Hyperplasia in a Pakistani Patient*
by: Khan, Zafaruddin, et al.
Published: (2014)

Depressive symptoms in patients diagnosed with benign prostatic hyperplasia
by: Pietrzyk, Barbara, et al.
Published: (2015)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
by: Hwang, Insang, et al.
Published: (2012)

Voltage-gated sodium channels were differentially expressed in human normal prostate, benign prostatic hyperplasia and prostate cancer cells
by: SHAN, BIN, et al.
Published: (2014)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
by: Hung, S-C, et al.
Published: (2013)

Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia
by: Huang, Jin, et al.
Published: (2015)